- Home
- AUPH vs INDV Comparison
AUPH vs INDV Comparison
Compare AUPH & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | INDV |
|---|---|---|
| Founded | 1993 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 4.0B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AUPH | INDV |
|---|---|---|
| Price | $14.46 | $31.52 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | 896.2K | ★ 2.6M |
| Earning Date | 05-25-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5075.00 | ★ 8100.00 |
| EPS | ★ 2.07 | 1.64 |
| Revenue | $283,055,000.00 | ★ $1,239,000,000.00 |
| Revenue This Year | $17.35 | N/A |
| Revenue Next Year | $15.66 | N/A |
| P/E Ratio | ★ $6.98 | $19.52 |
| Revenue Growth | ★ 20.38 | 4.29 |
| 52 Week Low | $6.83 | $8.65 |
| 52 Week High | $16.54 | $38.00 |
Technical Indicators
Market Signals| Indicator | AUPH | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 41.45 |
| Support Level | $13.52 | $30.47 |
| Resistance Level | $15.23 | $36.52 |
| Average True Range (ATR) | 0.55 | 1.74 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 55.52 | 34.92 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease.